We report here on the cloning and functional characterization of human LAT1, a subunit of the amino acid transport system L. The hLAT1 cDNA, obtained from a human placental cDNA library, codes for a protein of 507 amino acids. When functionally expressed in mammalian cells together with the heavy chain of the rat 4F2 antigen (r4F2hc), hLAT1 induces the transport of neutral amino acids. When expressed independently, neither hLAT1 nor r4F2hc was capable of amino acid transport to any significant extent. Thus, the hLAT1-r4F2hc heterodimeric complex is responsible for the observed amino acid transport. The transport process induced by the heterodimer is Na ؉ independent and is not influenced by pH. It recognizes exclusively neutral amino acids with high affinity. LAT1-specific mRNA is expressed in most human tissues with the notable exception of the intestine.
Amino acids constitute an important group of nutrients essential for the growth and development of the fetus and these nutrients are transported from the mother to the fetus across the placenta. Several transport systems are expressed in the syncytiotrophoblast of the human placenta which mediate the placental transfer of amino acids (1, 2). Among these transport systems, system L is unique due to its Na ϩ -independence and specificity towards most of the nutritionally essential neutral amino acids. We have characterized this transport system at the functional level using human placental brush border membrane vesicles (3) and human choriocarcinoma cells (4, 5) . The molecular nature of this transport system however remains unknown. Recently, Kanai et al (6) have cloned a protein from rat C6 glioma cells which mediates the Na ϩ -independent transport of neutral amino acids when coexpressed in Xenopus laevis oocytes with the heavy chain of the 4F2 antigen (CD98). This protein, designated rLAT1, is not capable of amino acid transport on its own. But as a heterodimer with the heavy chain of 4F2 antigen (4F2hc), rLAT1 is capable of amino acid transport activity characteristic of system L. 4F2hc is also known to be associated with system y ϩ L amino acid transport activity (7) and a protein has recently been cloned which mediates y ϩ L transport function when coexpressed with 4F2hc (8) . Thus, 4F2hc is a common subunit which exhibits either system L or system y ϩ L activity depending on the second subunit which heterodimerizes with 4F2hc. rLAT1 exhibits significant amino acid sequence homology with a human protein called E16 with no known function (9) . Sequence comparison however reveals that E16 is a truncated protein. Here we report on the molecular cloning and transport function of the human fulllength E16 (called here as hLAT1) which, when coexpressed in mammalian cells with rat 4F2hc, mediates Na ϩ -independent, high-affinity transport of neutral amino acids. The hLAT1 cDNA was isolated from a human placental cDNA library. The amino acid transport process mediated by hLAT1/r4F2hc heterodimer exhibits characteristics similar to system L described in human placental brush border membrane vesicles. (10) .
MATERIALS AND METHODS

Materials
Screening of the human placental cDNA library. The cDNA probe used for the screening was a 567-bp fragment of human E16 cDNA (9) obtained by RT-PCR using mRNA isolated from human term placenta. The primers used were 5Ј-TCGGGAAGGGTGATGTGT-3Ј (upstream) and 5Ј-CGCAGAGCCAGTTGAAGA-3Ј (downstream). These primers amplified a region corresponding to the nucleotide position 168 -734 in the published sequence of the human E16 cDNA (9) . The PCR product was cloned into pGEM-T vector and sequenced to confirm its identity before using it as a probe in cDNA library screening. The probe was labeled with [␣-32 P]CTP by random priming using the ready-to-go oligolabeling beads. A human placental cDNA library was screened as described earlier (11, 12) . Positive clones were identified and the colonies purified by secondary screening.
DNA sequencing. Both sense and antisense strands of the cDNA were sequenced by primer walking using Taq DyeDeoxy terminator cycle sequencing in an automated Perkin-Elmer Applied Biosystems 377 Prism DNA sequencer. The sequence was analyzed using the GCG sequence analysis software package GCG version 7.B (Genetics Computer Group, Inc., Madison, WI). Database searches were done using the GenBank Program Blast (13) .
Functional expression of the cDNA in HRPE cells. The vaccinia virus expression system was used to functionally characterize the cloned cDNA as described previously (14, 15) . Both hLAT1 and 4F2hc were cloned into plasmid vectors such that the sense transcription is under the control of T7 promoter. The hLAT1 was cloned in pSPORT and the r4F2hc was cloned in pBluescript SK II. The cDNAs were transfected into HRPE cells grown in 24-well tissue culture plates using lipofectin and the functional expression of the cDNA was determined 12 h later by measuring radiolabeled amino acid uptake. One microgram of the plasmid carrying the specified cDNA (4F2hc or hLAT1) was used per well. Sister wells transfected identically with empty vector served as control. The DNA:lipofectin ratio was kept constant at 1:2.5 in all cases by substituting the empty vector DNA wherever necessary. The transport buffer was composed of either 25 mM Hepes/Tris (pH 7.5) or 25 mM Mes/Tris (pH 6.0) supplemented with 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , and 5 mM glucose. When the effect of Na ϩ on amino acid uptake was measured, the NaCl in the buffer was replaced with N-methyl-D-glucamine (NMDG) chloride. The incubation time for the transport measurements was 5 min, following which the uptake medium containing the radioactive substrate was aspirated off and the cells washed with 2 ϫ 2 ml of ice-cold transport buffer. The cells were then solubilized in 0.5% SDS in 0.2 N NaOH, transferred to vials and radioactivity associated with the cells quantitated by liquid scintillation spectrometry. The experiments were repeated 2-4 times, each done in duplicate or triplicate. Data are presented as means Ϯ SEM of these replicate measurements.
Northern blot analysis. A commercially available Northern blot (Clontech) containing 2 g of mRNA isolated from different human tissues was used to determine the expression of hLAT1 transcripts in various tissues. The filter was sequentially probed, first with the hLAT1 cDNA probe used in library screening and later following stripping, with the human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA probe. Both the probes were labeled with [␣-32 P]dCTP by random priming using the ready-to-go oligo labeling kit. The hybridization and posthybridization washings were done under high stringency conditions.
RESULTS AND DISCUSSION
Isolation of hLAT1 cDNA from a human placental library. Recently, Kanai et al. (6) reported on the cloning of a cDNA which, when coexpressed with 4F2hc cDNA in X. laevis oocytes, induced Na ϩ -independent uptake of neutral amino acids. This cDNA was referred to as rat LAT1. Amino acid sequence comparison of the rat LAT1 cDNA with sequences in the SwissProt database showed 100% identity with the rat integral membrane protein E16 (TA1 protein) (16) and 90% identity (92% similarity) with the human integral membrane protein E16 (9) . Both the rat and human E16s however are shorter at the N-terminal end by 266 amino acids. The Met-1 (the first amino acid residue) of E16 protein aligns, and is in-frame with Met-272 of the rat LAT1 protein. The rat E16 (TA1) has been described as a highly conserved oncofetal protein associated with liver development, carcinogenesis and cell activation. The human homolog has been shown to be a transiently expressed membrane protein with the rapid degradation signal AUUUA, and is said to be involved in cell activation in all myeloid and lymphoid cells and in primary lymphocytes as well. The sequence homology among rLAT1, rE16 (TA1) and hE16 clearly indicates that the rat and human E16 are truncated forms of LAT1 albeit the reason for the presence of the truncated form of LAT1 both in the rat as well as in humans is not known. The function of these truncated E16s has not been investigated. Therefore, we screened a human placental cDNA library using a fragment of the human E16 cDNA as a probe to isolate the full-length human E16 cDNA and subsequently test its amino acid transport function. The cDNA probe was obtained by designing primers using the published sequence of hE16 followed by RT-PCR of poly(A) ϩ RNA isolated from human term placenta. Several positive clones were identified in the screening of the library. Initial sequencing of the 5Ј-end of these clones indicated the presence of three full-length clones and one clone truncated at the 5Ј-end with respect to LAT1. One of the full-length hLAT1 clones was arbitrarily chosen for further characterization.
Structure of hLAT1. The cDNA is 4670 bp long (GenBank Accession No. AF104032) with a single open reading frame of 1524 bp, including the termination codon. The 5Ј-untranslated region is much smaller (66 bp) compared to the 3Ј-untranslated region (3081 bp). The translation start site is preceded by a Kozak consensus sequence of CAGAGC (17) . The cDNA codes for a highly hydrophobic protein with a predicted molecular mass of 55 kDa and pI of 7.9. The 507 amino acids in the hLAT1 protein forms 12 putative transmembrane domains as determined by Kyte-Doolittle hydropathy analysis (18) . The comparison of amino acid sequences of hLAT1 and rLAT1 is presented in Fig. 1 . The two proteins are highly conserved with an amino acid sequence identity of 91% and similarity of 94%.
Comparison of the amino acid sequence of hLAT1 with that of hE16 (9) confirms that the latter is a truncated product of hLAT1. When modeled similar to other known membrane proteins with both the N-terminus and C-terminus towards the cytoplasm, the amino acid sequence exhibits one conserved motif for N-linked glycosylation (Asn-230). Interestingly, this Asn residue is not conserved in rLAT1, which has been convincingly shown not to be glycosylated by in vitro translation studies using EndoH and pancreatic microsomes (6) . It seems likely that hLAT1 is a glycosylated protein in contrast to rLAT1. Similar differences in glycosylation of a highly conserved protein across the species is not uncommon and has been reported with respect to the murine and human homologs of the reduced folate transporter (19) . The amino acid sequence of hLAT1 has one site with a conserved motif for casein kinase II-dependent phosphorylation (Ser-113), two sites with protein kinase C-dependent phosphorylation motifs (Ser-189 and Ser-346) and one site for tyrosine kinasedependent phosphorylation (Tyr-119). All these phosphorylation sites are also present in rLAT1.
Functional expression of hLAT1.
To analyze the amino acid transport function of hLAT1, we used the vaccinia virus expression system. We expressed functionally the hLAT1 cDNA and the rat 4F2hc cDNA either individually or together and measured the uptake of tryptophan at pH 6.0 in the absence of Na ϩ ( Fig.  2A) . There was no significant stimulation of radiolabeled tryptophan uptake in comparison to emptyvector transfected cells when 4F2hc was expressed alone (10.0 Ϯ 0.3 pmol/10 6 cells/5 min vs 10.6 Ϯ 0.2 pmol/10 6 cells/5 min). Under similar conditions, expression of hLAT1 alone resulted in ϳ45% increase in the uptake of tryptophan (14.5 Ϯ 0.2 pmol/10 6 cells/5 min). However, when the two proteins were coexpressed, tryptophan uptake increased 2.5-fold compared to control values (27.2 Ϯ 0.1 pmol/10 6 cells/5 min). This increase was much greater than the increase expected from a simple additive effect arising from the independent operation of hLAT1 and r4F2hc. These results not only confirm that hLAT1 and r4F2hc interact with each other to form the functional transporter but also show that the two interacting proteins, though from two different species, can still form a functional heterodimer. The 4F2hc protein is also highly conserved across the species with 65% identity and 72% similarity between the human and the rat proteins. The significant increase in tryptophan uptake observed in cells transfected with hLAT1 alone is possibly due to the interaction between the heterologously Vol. 255, No. 2, 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS expressed hLAT1 and the constitutively expressed 4F2hc in HRPE cells. There is evidence for ubiquitous expression of 4F2hc (20) . The effect of Na ϩ and pH on the transport activity mediated by the hLAT1-r4F2hc heterodimer was investigated by measuring the uptake of tryptophan in HRPE cells coexpressing these two proteins at two different pH, 7.5 and 6.0, in the presence and absence Na ϩ (Fig. 2B) . We found no significant differences in the uptake when measured under these different experimental conditions. Thus the transport function of the hLAT1-r4F2hc heterodimer is not dependent on Na ϩ and H ϩ . We then investigated the substrate specificity of the transport process mediated by the hLAT1-r4F2hc heterodimer by measuring the uptake of various radiolabeled amino acids (Table 1 ) and also by assessing the ability of various unlabeled amino acids to compete with radiolabeled tryptophan uptake ( Table 2) in HRPE cells coexpressing these two proteins. These measurements were made with a 5 min incubation at pH 7.5 and in the presence of Na ϩ . As seen in Table 1 , large neutral amino acids such as tryptophan, phenylalanine, leucine and histidine were transported by hLAT1 when coexpressed with 4F2hc. Neither r4F2hc nor hLAT1 was individually able to mediate the uptake of these amino acids. Uptake of charged amino acids such as glutamate and arginine were not stimulated in cells coexpressing hLAT1 and r4F2hc. Competition studies using unlabeled amino acids showed that the uptake of labeled tryptophan mediated by the hLAT1-r4F2hc heterodimer was inhibitable by several unlabeled neutral amino acids (tryptophan, phenylalanine, leucine, isoleucine, and histidine) and BCH, a prototypical substrate of amino acid transporter system L. Glutamine and threonine are poor substrates of the transport process, evidenced from their ability to inhibit tryptophan uptake by only ϳ30%. Short neutral amino acids such as alanine, proline, and methylaminoisobutyric acid (MeAIB) failed to inhibit the tryp- tophan uptake, suggesting that these amino acids are not recognized by the hLAT1-r4F2hc transporter complex. These functional characteristics are similar to those obtained with system L-mediated tryptophan uptake in human placental brush border membrane vesicles (3) and also with the transport process mediated by the cloned rLAT1 (6) . The kinetics of tryptophan uptake mediated by the hLAT1-r4F2hc heterodimeric complex was analyzed by measuring tryptophan uptake in HRPE cells cotransfected with hLAT1 cDNA and r4F2hc cDNA. Uptake measurements were made at pH 7.5 and in the presence of Na ϩ . Initial uptake rates were obtained over the concentration range of 5-250 M tryptophan with a 5-min incubation. Cells transfected with vector alone served as the control for endogenous tryptophan uptake activity. The kinetic constants were initially calculated from the data by non-linear regression (Fig.  3A) and confirmed by linear regression (Fig. 3B) . The transport process was saturable in control cells as well as in cells coexpressing hLAT1 and 4F2hc. In both instances, the Michaelis-Menten constant (K t ) for the transport process was comparable (16.6 Ϯ 1.6 M in cells expressing the two proteins and 14.4 Ϯ 1.4 M in control cells). However, the maximal velocity (V max ) increased 3.5-fold (4.9 Ϯ 0.2 vs 1.3 Ϯ 0.1 nmol/10 6 cells/5 min) as the result of coexpression of hLAT1 and r4F2hc. These data suggest that HRPE cells express an amino acid transport system which is kinetically similar to the transport process mediated by hLAT1-r4F2hc complex. Thus the K t for tryptophan for the transport process mediated by hLAT1-r4F2hc hetrodimer is ϳ15 M. This value is similar to the value obtained for tryptophan transport in human placental brush border membrane vesicles (3).
Expression of LAT1 in various tissues of human origin.
This was investigated by Northern blot analysis using a commercially available multiple tissue blot (Fig. 4) . Most of the tissues were positive for LAT1 transcript which showed a single hybridization signal of 5.0 kb in size. The hybridization signal was very intense in lanes containing poly (A) ϩ RNA from placenta, brain, and skeletal muscle, indicating that these tissues have very high levels of the LAT1 transcript. The signals were comparatively weak but easily detect- able in other tissues (heart, colon, thymus, spleen, kidney, liver, lung and leukocytes). The size of the LAT1-specific transcript in the liver is about 1 kb shorter than that seen in rest of the tissues. The transcript was not detectable in the intestine. Thus LAT1 transcripts are detected in humans in all the tissues tested except intestine. In contrast, LAT1-specific transcripts have been reported to be present in the rat only in brain, spleen, colon, testis and placenta (6) . Of the tissues tested in the rat, heart, liver, skeletal muscle, kidney, jejunum, and ileum were negative for the LAT1 transcript.
To summarize, we have reported here on the cloning of the human LAT1, a subunit of system L amino acid transporter. When coexpressed with the 4F2 heavy chain, it induces the transport of large neutral amino acids in a Na ϩ -and H ϩ -independent manner. Neither LAT1 nor 4F2hc by themselves is capable of this induction to any significant extent. LAT1-specific transcripts are detectable in humans in several tissues, with the notable exception of the intestine.
